Trials / Withdrawn
WithdrawnNCT02149771
Combination Treatment for Advanced Liver Cancer
Transarterial Chemoembolisation (TACE) Combined With Endovascular Implantation of Bare Stent and Iodine-125 Seed Strand for the Treatment of Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis Versus TACE Alone
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether TACE combined endovascular stent implantation confers a survival benefit over TACE alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | chemoembolization | Conventional chemoembolisation by administering Doxorubicin and Oxaliplatin mix with 5-20 mL iodised oil.Gelatine sponge was used to embolise the feeding artery of the tumour.Repeat if patients with viable lesions demonstrated by CT or MRI. |
| DEVICE | endovascular stents implantation | Bare stents implant within portal vein. |
| PROCEDURE | iodine-125 seed strand implantation | Iodine-125 seed strand implant within portal vein. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-05-01
- Completion
- 2016-09-01
- First posted
- 2014-05-29
- Last updated
- 2018-04-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02149771. Inclusion in this directory is not an endorsement.